DA Davidson initiates QXO coverage with Buy, $26 target
DA Davidson analyst Garik Shmois initiates coverage of QXO with a Buy rating and a $26 price target, citing TopBuild’s role in accelerating its path toward $4B-$5.5B EBITDA by 2030.
QXO QXO initiated with a Buy at DA Davidson DA Davidson analyst Garik Shmois initiated coverage of QXO with a Buy rating and $26 price target.
QXO is a long-term story, but the TopBuild acquisition accelerates the company's path toward $4B-$5.5B in EBITDA by 2030, the analyst tells investors in a research note.
The firm anticipates that, over time, QXO's synergy capture will become more evident in 2027-2028, adding that this sets the stage for positive catalysts and an attractive risk/reward profile for patient investors.